GlaxoSmithKline Plc (GSK) will reveal detailed results today on an experimental treatment for diabetes that’s part of the reason for a $2.6 billion hostile takeover bid for Human Genome Sciences Inc. (HGSI) , its partner on the drug.
THURSDAY, May 17 (HealthDay News) -- Many people know diabetes -- both type 1 and type 2 -- can take a serious toll on physical health. But these blood-sugar disorders also can affect your emotions and, in turn, your emotions can wreak havoc on your diabetes control.
TUESDAY, May 22 (HealthDay News) -- Healthier lifestyles and better disease management led to a sharp drop in death rates for Americans with diabetes between 1997 and 2006, especially deaths caused by heart disease and stroke, a new federal government report shows.